Skip to content
Open access

Multi-omics characterization of P2RX4-associated immune microenvironment features and proof-of-concept observations of peritumoral radiomic phenotypes in TNBC

Sep 2026 · BMC Medical Imaging · 0 citations

TL;DR

In the analyzed TNBC datasets, P2RX4 expression was associated with CD163 expression and hypoxia-related transcriptional features, and across transcriptomic analyses, P2RX4 expression was positively associated with CD163 expression and hypoxia-related transcriptional features.

Abstract

Triple-negative breast cancer (TNBC) is characterized by a highly heterogeneous and immunosuppressive tumor microenvironment (TME). While the ATP-gated receptor P2RX4 is associated with inflammation, its cell-specific expression patterns, associations with TME features, and potential imaging correlates in TNBC remain incompletely characterized. This study aimed to characterize the cell-specific expression of P2RX4, its association with the tumor immune microenvironment, and its potential non-invasive imaging correlates in TNBC. We integrated single-cell RNA sequencing from GEO and bulk transcriptomics from TCGA-BRCA, with cross-cohort validation using the METABRIC cohort. Additionally, we incorporated dynamic contrast-enhanced MRI data from TCIA to provide exploratory macroscopic observations of the 3-mm peritumoral habitat. scRNA-seq analysis showed that P2RX4 expression was predominantly enriched in epithelial/tumor cells in the analyzed TNBC samples. Across transcriptomic analyses, P2RX4 expression was positively associated with CD163 expression and hypoxia-related transcriptional features, with modest correlation magnitudes. P2RX4 and P2RX7 showed different correlation patterns with selected microenvironment-related markers. In the analyzed TNBC cohort, P2RX4 expression was negatively correlated with VIM and positively correlated with CDH1; these associations do not establish an effect on EMT or stromal remodeling. Exploratory survival analyses showed an association between high P2RX4 expression and favorable overall survival in the Pan-BRCA cohort but not in the TNBC subgroup; this association was sensitive to the data-driven expression cutpoint. Imaging observations in four matched MRI cases were descriptive and hypothesis-generating and do not establish an imaging–molecular association or validate an imaging biomarker. In the analyzed TNBC datasets, P2RX4 expression was associated with CD163 expression and hypoxia-related transcriptional features. These molecular findings, together with descriptive peritumoral MRI observations in four cases, generate hypotheses for future studies of P2RX4-associated microenvironmental features and potential imaging correlates.

Read PDF

Similar papers

Open access Sep 2026

Integrative multi-omics characterization of KLRB1/CD161 in diffuse large B-cell lymphoma: associations with immune context, subtype biology, and therapeutic response

Background The tumor immune microenvironment (TME) of diffuse large B-cell lymphoma (DLBCL) displays pronounced heterogeneity, and existing immunotherapeutic approaches achieve only suboptimal outcomes for a considerable proportion of affected individuals. CD161—a C-type lectin receptor whose coding gene is KLRB1—has l...

Er-Wei Li, Ying-Ying Tang, Yuanyuan Wanyan et al. · 0 citations
Open access Sep 2026

Integrated Pan-Cancer, Single-Cell, and Spatial Transcriptomic Analyses Identify ZDHHC12 as a Biomarker Associated with Macrophage Infiltration and the Immune Landscape in Glioma

ZDHHC12 may serve as a candidate pan-cancer prognostic biomarker and its expression was broadly correlated with immune cell recruitment- and activation-related signatures in glioma and in glioma, and was associated with patient prognosis.

Chao Zhang, Da Teng, Yu Wang et al. · 0 citations
Open access Sep 2026

B3GNT3 defines a spatially restricted dysfunctional T-cell niche and predicts immunotherapeutic outcomes in lung adenocarcinoma

Immunotherapy response in lung adenocarcinoma (LUAD) remains highly heterogeneous, underscoring the need for biologically informative markers of tumor immune dysregulation. B3GNT3, a glycosyltransferase implicated in several malignancies, is poorly characterized in LUAD with respect to the tumor immune microenvir...

Yao-Lin Zheng, Zhi-Hua Qiao, Dai Cao et al. · 0 citations
Open access Aug 2026

PLK1/FOXM1-associated tumor-cell state and macrophage-related immune features in endometrial cancer

The PLK1/FOXM1-associated tumor-cell state may represent a distinct molecular feature associated with proliferative activity, invasive phenotypes, and macrophage-related immune features in EC and is highlighted in potential therapeutic directions for future investigation.

Long-Wei Li, Yun-yun Xiao, Ya-Ping Wang et al. · 0 citations
Open access Oct 2026

Integrated Multi-Omics Characterization of WASHC2C Reveals Cancer-Specific Molecular, Clinical, Immune, and Cellular Associations

WASHC2C encodes a WASH-complex scaffold implicated in actin remodeling, endosomal organization, and intracellular trafficking, yet its cancer-specific molecular and clinical relevance remains insufficiently defined, particularly in the context of the closely related paralogue WASHC2A. We performed an integrated pan-can...

Hakeemah H. Al-Nakhle · 0 citations
Sep 2026

Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis.

The results demonstrate that S100A10 is significantly upregulated in HCC and is closely associated with poor prognosis and an immunosuppressive state, and provides a theoretical basis for combinatorial strategies targeting metabolism and immunotherapy.

Jing-Xu Zhang, Gang-Gang Wang, Zhijie Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.